dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniv Taubate
dc.contributorCentro Univ Araraquara
dc.contributorClin Hosp State São Paulo
dc.contributorUniversidade Federal de São Carlos (UFSCar)
dc.date.accessioned2014-05-20T13:45:44Z
dc.date.accessioned2022-10-05T14:12:19Z
dc.date.available2014-05-20T13:45:44Z
dc.date.available2022-10-05T14:12:19Z
dc.date.created2014-05-20T13:45:44Z
dc.date.issued2007-10-04
dc.identifierRegulatory Peptides. Amsterdam: Elsevier B.V., v. 143, n. 1-3, p. 28-33, 2007.
dc.identifier0167-0115
dc.identifierhttp://hdl.handle.net/11449/16118
dc.identifier10.1016/j.regpep.2007.01.013
dc.identifierWOS:000249459100003
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3891224
dc.description.abstractWe have studied the effects of L-NG-nitro arginine methyl esther (L-NAME), L-arginine (LAR), inhibitor and a donating nitric oxide agent on the alterations of salivary flow, water intake, arterial blood pressure (MAP) and heart rate (HR) induced by the injection pilocarpine into the subfornical organ (SFO). Rats (Holtzman 250-300 g) were anesthetized with 2, 2, 2-tribromoethanol (20 mg/100 kg b. wt.) and a stainless steel carmula were implanted into their SFO. The volume of injection was 0.2 mu l. The amount of saliva secretion was studied over a 5-min period. Pilocarpine (40 mu g), L-NAME (40 mu g) and LAR (30 mu g) were used in all experiments for the injection into the SFO. Pilocarpine (10, 20, 40, 80 and 160 mu g) injected into SFO elicited a concentration-dependent increase in salivary secretion. L-NAME injected prior to pilocarpine into the SFO increased salivary secretion and water intake due to the effect of pilocarpine. LAR injected prior to pilocarpine into the SFO attenuated the salivary secretion and water intake. Pilocarpine, injected into the SFO increased the MAP and decreased heart rate (HR). L-NAME injected prior to pilocarpine into the SFO potentiated the pressor effect of pilocarpine with a decrease in HR. LAR injected into the SFO prior to pilocarpine attenuated the increase in MAP with no changes in HR. The present study suggests that the SFO nitrergic cells interfere in the cholinergic pathways implicated in the control of salivary secretion, fluid and cardiovascular homeostasis. (c) 2007 Elsevier B.V All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationRegulatory Peptides
dc.relation0,512
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectpilocarpine
dc.subjectsubfornical organ
dc.subjectnitric oxide
dc.subjectsaliva
dc.subjectfluid and cardiovascular balance
dc.titleFunctional relationship between subfrnical organ cholinergic stimulation and nitrergic activation influencing cardiovascular and body fluid homeostasis
dc.typeArtigo


Este ítem pertenece a la siguiente institución